Latest Nan Fung Group Holdings Ltd Stock Portfolio

Nan Fung Group Holdings Ltd Performance:

2025 Q4: 7.36%YTD: 15.19%2024: 3.26%

Performance for 2025 Q4 is 7.36%, and YTD is 15.19%, and 2024 is 3.26%.

About Nan Fung Group Holdings Ltd and 13F Hedge Fund Stock Holdings

On 2026-02-13, the fund reported it's updated stock portfolio. In the 13F Holdings report, Nan Fung Group Holdings Ltd reported an equity portfolio of $111.7 Millions as of 31 Dec, 2025.

The top stock holdings of Nan Fung Group Holdings Ltd are , , . The fund has invested 22.1% of it's portfolio in EVOMMUNE INC and 15.3% of portfolio in MAPLIGHT THERAPEUTICS INC.

The fund managers got completely rid off JOBY AVIATION INC (JOBY) stocks. They significantly reduced their stock positions in ROCKET LAB CORP. Nan Fung Group Holdings Ltd opened new stock positions in EVOMMUNE INC, PROCORE TECHNOLOGIES INC (PCOR) and CYBIN INC (CYBN).

Nan Fung Group Holdings Ltd Annual Return Estimates Vs S&P 500

Our best estimate is that Nan Fung Group Holdings Ltd made a return of 7.36% in the last quarter. In trailing 12 months, it's portfolio return was 15.19%.

Performance
S&P 500

New Buys

Ticker	$ Bought
evommune inc	24,670,500
maplight therapeutics inc	17,060,100
procore technologies inc	3,876,970
cybin inc	3,762,800

New stocks bought by Nan Fung Group Holdings Ltd

Additions

No additions were made to existing positions by Nan Fung Group Holdings Ltd

Reductions

Ticker	% Reduced
rocket lab corp	-87.05

Nan Fung Group Holdings Ltd reduced stake in above stock

Sold off

Ticker	$ Sold
joby aviation inc	-3,507,540

Nan Fung Group Holdings Ltd got rid off the above stocks

Sector Distribution

Nan Fung Group Holdings Ltd has about 62.6% of it's holdings in Others sector.

Sector	%
Others	62.6
Healthcare	33.9
Technology	3.5

Market Cap. Distribution

Nan Fung Group Holdings Ltd has about 17.1% of it's portfolio invested in the large-cap and mega-cap stocks.

Category	%
UNALLOCATED	62.6
MID-CAP	13.7
LARGE-CAP	12.8
SMALL-CAP	5.8
MEGA-CAP	4.3

Stocks belong to which Index?

About 26.2% of the stocks held by Nan Fung Group Holdings Ltd either belong to S&P 500 or RUSSELL 2000 index.

Index	%
Others	73.8
RUSSELL 2000	21
S&P 500	5.2

Top 5 Winners (%)		%
RANI	rani therapeutics hldgs inc	170.1 %
REPL	replimune group inc	132.0 %
TRDA	entrada therapeutics inc	77.2 %
RVMD	revolution medicines inc	70.6 %
	lb pharmaceuticals inc	41.0 %

Top 5 Winners ($)		$
	lb pharmaceuticals inc	1.9 M
MDGL	madrigal pharmaceuticals inc	1.5 M
	oculis holding ag	1.2 M
INCY	incyte corp	0.8 M
KYMR	kymera therapeutics inc	0.7 M

Top 5 Losers (%)		%
	bolt projs hldgs inc	-78.9 %
	ishares ethereum tr	-28.8 %
	ishares bitcoin trust etf	-23.6 %
RXRX	recursion pharmaceuticals in	-16.2 %
BGNE	beone medicines ltd	-10.8 %

Top 5 Losers ($)		$
BGNE	beone medicines ltd	-0.6 M
RXRX	recursion pharmaceuticals in	-0.5 M
	ishares ethereum tr	-0.5 M
	ishares bitcoin trust etf	-0.2 M
	bolt projs hldgs inc	-0.1 M

Nan Fung Group Holdings Ltd Holdings Map

This heatmap illustrates the top 50 positions within the fund's portfolio.

Current Stock Holdings of Nan Fung Group Holdings Ltd

Nan Fung Group Holdings Ltd has 27 stocks in it's portfolio. About 79.8% of the portfolio is in top 10 stocks. BGNE proved to be the most loss making stock for the portfolio. was the most profitable stock for Nan Fung Group Holdings Ltd last quarter.

Last Reported on: 13 Feb, 2026

Ticker	Namesorted ascending	% Portfolio	Shares Held	$ Value	Type	% Change
ACAD	acadia pharmaceuticals inc	2.46	102,984	2,750,700	unchanged	0.00

ARGX	argenx se	2.11	2,800	2,354,660	unchanged	0.00

ASND	ascendis pharma a/s	2.60	13,600	2,900,060	unchanged	0.00

BCYC	bicycle therapeutics plc	0.44	68,943	488,116	unchanged	0.00

BGNE	beone medicines ltd	4.28	15,722	4,776,500	unchanged	0.00

BOLT	bolt biotherapeutics inc	0.29	58,347	319,041	unchanged	0.00

CYBN	cybin inc	3.37	460,000	3,762,800	new

HRMY	harmony biosciences hldgs in	0.91	27,049	1,012,170	unchanged	0.00

INCY	incyte corp	5.22	59,022	5,829,600	unchanged	0.00

JOBY	joby aviation inc	0.00	0.00	0.00	sold off	-100

KYMR	kymera therapeutics inc	2.15	30,875	2,402,380	unchanged	0.00

LAB	standard biotools inc	2.16	1,883,180	2,410,470	unchanged	0.00

MDGL	madrigal pharmaceuticals inc	6.19	11,872	6,913,540	unchanged	0.00

PCOR	procore technologies inc	3.47	53,299	3,876,970	new

RANI	rani therapeutics hldgs inc	0.60	493,584	666,338	unchanged	0.00

REPL	replimune group inc	0.55	63,719	619,349	unchanged	0.00

RVMD	revolution medicines inc	1.37	19,253	1,533,500	unchanged	0.00

RXRX	recursion pharmaceuticals in	2.18	595,287	2,434,720	unchanged	0.00

RYTM	rhythm pharmaceuticals inc	4.71	49,120	5,257,800	unchanged	0.00

TRDA	entrada therapeutics inc	0.45	49,082	504,563	unchanged	0.00